WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
about
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
@en
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
@nl
type
label
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
@en
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
@nl
prefLabel
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
@en
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
@nl
P2093
P2860
P1433
P1476
WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
@en
P2093
Dongmei Yan
Haining Yuan
Jianfei Fang
Linglan Tu
Liyan Cheng
Xiaoju Wang
Xiaoliang Zheng
P2860
P2888
P356
10.1038/S41598-017-15749-Z
P407
P577
2017-11-13T00:00:00Z